4.8 Article

Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis

Journal

GASTROENTEROLOGY
Volume 160, Issue 4, Pages 1256-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2020.11.006

Keywords

Stomach Cancer; Colorectal cancer; Electrophiles; Chemoprevention

Funding

  1. US Department of Defense [W81XWH-18-1-0301]
  2. National Institutes of Health [R01CA190612, P01CA116087, P01CA028842, R21AI142042, S10OD016245]
  3. Veterans Affairs Merit Review grants [I01BX001453, I01CX002171, I01BX004366]
  4. Crohn's and Colitis Foundation [703003]
  5. Thomas F. Frist Sr. Endowment
  6. Vanderbilt Center for Mucosal Inflammation and Cancer
  7. Vanderbilt University Medical Center Digestive Disease Research Center - National Institutes of Health [P30DK058404]
  8. Vanderbilt Ingram Cancer Center support grant [P30CA068485]
  9. Preclinical Imaging Subcore [P30DK058404]
  10. Tissue Morphology Subcore [P30DK058404]

Ask authors/readers for more resources

The study revealed that dicarbonyl electrophiles are linked to inflammation in the gastrointestinal tract and may contribute to cancer development. The drug EtHOBA can inhibit and reduce isoLG adducts and DNA damage in cell nuclei, lowering the somatic mutation frequency.
BACKGROUND & AIMS: Inflammation in the gastrointestinal tract may lead to the development of cancer. Dicarbonyl electrophiles, such as isolevuglandins (isoLGs), are generated from lipid peroxidation during the inflammatory response and form covalent adducts with amine-containing macromolecules. Thus, we sought to determine the role of dicarbonyl electrophiles in inflammation-associated carcinogenesis. METHODS: The formation of isoLG adducts was analyzed in the gastric tissues of patients infected with Helicobacter pylori from gastritis to precancerous intestinal metaplasia, in human gastric organoids, and in patients with colitis and colitis-associated carcinoma (CAC). The effect on cancer development of a potent scavenger of dicarbonyl electrophiles, 5-ethyl-2-hydroxybenzylamine (EtHOBA), was determined in transgenic FVB/N insulin-gastrin (INS-GAS) mice and Mongolian gerbils as models of H pylori-induced carcinogenesis and in C57BL/6 mice treated with azoxymethane-dextran sulfate sodium as a model of CAC. The effect of EtHOBA on mutations in gastric epithelial cells of H pylori-infected INS-GAS mice was assessed by whole-exome sequencing. RESULTS: We show increased isoLG adducts in gastric epithelial cell nuclei in patients with gastritis and intestinal metaplasia and in human gastric organoids infected with H pylori. EtHOBA inhibited gastric carcinoma in infected INS-GAS mice and gerbils and attenuated isoLG adducts, DNA damage, and somatic mutation frequency. Additionally, isoLG adducts were elevated in tissues from patients with colitis, colitis-associated dysplasia, and CAC as well as in dysplastic tumors of C57BL/6 mice treated with azoxymethane-dextran sulfate sodium. In this model, EtHOBA significantly reduced adduct formation, tumorigenesis, and dysplasia severity. CONCLUSIONS: Dicarbonyl electrophiles represent a link between inflammation and somatic genomic alterations and are thus key targets for cancer chemoprevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available